Fertility

Fertility is the capacity to conceive and carry. It tracks progesterone, thyroid, energy, and low chronic stress more than a single lab number. Pregnancy is high metabolic demand.

Practice

Medical fertility care when needed. Support thyroid, progesterone context, sugar oxidation, and lower seed oils. Standard fertility workup (hormone panels, imaging, partner evaluation) remains the necessary first step. See Pregnancy, Progesterone, Thyroid, PCOS, Harm reduction.

Female

Don't restrict salt, sugar, or calories

Low blood volume and low blood sugar both raise cortisol, and cortisol drives the estrogen dominance pattern that suppresses fertility. Deliberate under-eating or a low-salt diet in the preconception window works against the goal, not toward it.

The attempt to restrict weight gain in pregnancy has expanded the problem of eclampsia beyond its association with poverty, into the more affluent classes.

— Ray Peat

A diet low in sodium and protein probably kills many more people than has been documented... the common salt restriction for old-age hypertension is just as irrational as is salt-restriction in pregnancy or in shock.

— Ray Peat

Heavy menstruation

Heavy periods are commonly treated with hormonal birth control; the useful target is the underlying cause instead of the bleeding itself.

Hypothyroidism is the basic cause of heavy menstruation. Things strong enough to kill an embryo can't be harmless to a person.

— Ray Peat

See Hypothyroidism and Thyroid for correcting the underlying deficiency rather than suppressing the cycle.

Aspirin, progesterone, and uterine circulation

Peat grouped aspirin with progesterone and vitamin E as fertility-supporting through a shared mechanism, suppressing a specific prostaglandin and improving blood flow to the uterus:

Aspirin, like progesterone or vitamin E, can improve fertility, by suppressing a prostaglandin, and improving uterine circulation.

— Ray Peat

A randomized trial in IVF patients found 100 mg daily aspirin nearly doubled the number of follicles and oocytes retrieved, and raised pregnancy rate to 45% versus 28% with placebo (implantation rate 17.8% versus 9.2%).

For a history of intrauterine growth retardation or clotting-related pregnancy loss, aspirin has a protective effect, alongside a clotting-risk caveat that limits its use near delivery.

It seems to protect the fetus against intrauterine growth retardation, an effect that I think relates to aspirin's ability to protect in several ways against excesses of unsaturated fatty acids and of estrogen. But, since aspirin can interfere with blood clotting, its use around the time of childbirth can be risky, and it is best to correct the problem early enough that aspirin isn't needed.

— Ray Peat

Coordinate any aspirin use with an obstetric provider; this is not a substitute for addressing the underlying thyroid/progesterone/estrogen balance.

Thyroid and progesterone production

Adequate protein and good thyroid function support the body's own progesterone production; even without ovaries, the adrenal glands and brain continue to produce it, and estrogen dominance or progesterone deficiency directly obstructs thyroid secretion, creating a self-reinforcing cycle.

Ovulation mechanics

Mast cells are required for the follicle to rupture during ovulation; mast-cell suppression (from some allergy medications, for instance) can itself prevent ovulation.

Vitamin E and extending fertility

Vitamin E and progesterone together can extend the fertile window past its normal end in aging animals.

Old medical and obstetric journals report women who gave birth long after menopause, including one who had a child at 59 years and 5 months, ten years after her menopause.

I found that old animals had too little oxygen in their uterus to keep the embryo alive at the time it would normally be ready to implant itself in the uterus. Giving estrogen to a young animal causes a similar lack of oxygen in the uterus, and prevents implantation of the embryo. At the time old animals would normally have become infertile, they remain fertile if they are given a supplement of vitamin E and progesterone. It is now established that aging animals, at the time they become infertile, are deficient in progesterone, but still produce estrogen.

— Ray Peat

In aging animals, adequate progesterone with falling estrogen relative to it, not egg supply, limits reproductive aging. An aged uterus can support pregnancy when given the right hormonal support.

In 105 infertile women with polycystic ovary syndrome undergoing ICSI, eight weeks of vitamin E (400 mg/day) plus vitamin D3 (50,000 IU every two weeks) raised pregnancy, clinical pregnancy, and implantation rates versus placebo. Serum MDA rose and total antioxidant capacity fell in both arms after treatment; neither follicular nor serum MDA or TAC tracked ICSI outcomes, so the pregnancy gain was not explained by those antioxidant markers.

Male

Fertility depends on the health of both parents: thyroid, pregnenolone and vitamin E matter as much for male fertility as thyroid, progesterone and vitamin E do for female fertility.

Keep testosterone from converting to estrogen

Aromatase converts testosterone to estradiol under stress and inflammation; blocking that conversion is a direct lever on male fertility, not just a female one.

Coffee, progesterone, flavonoids, and aspirin. Aspirin is a major MTOR inhibitor and aromatase inhibitor.

— Ray Peat

Coffee, aspirin, and dietary flavonoids (from fruit) are practical aromatase-inhibiting choices. Correcting thyroid function and removing dietary PUFA apply equally to the male partner. See Thyroid and PUFA.

In NOA (n = 76, including 4 anastrozole-pretreated) versus OA with normal spermatogenesis (n = 18), testicular aromatase was mainly Leydig-cell localized and higher in NOA; serum T/E2 did not track ITT/ITE2, while higher aromatase intensity aligned with lower ITT, higher ITE2, and a lower ITT/ITE2 ratio (about 42,590 to 25,774; 3,177 to 5,856; 15.7 to 4.6 across +/++/+++). High aromatase (+++) independently predicted failed micro-TESE sperm retrieval (multivariate OR about 22.8). See Aromatase.

Vitamin D

In vitamin D-deficient infertile men with oligoasthenozoospermia (n = 60), weekly 60,000 IU cholecalciferol plus daily calcium for 6 months raised progressive sperm motility (22.91% to 35.12%) and sperm concentration (19.72 to 33.63 million/mL); LH, FSH, testosterone, and estradiol were unchanged, and clinical pregnancy was 8.33%. See Vitamin D3.

Vitamin A / RAR-α

Retinoic acid signaling through RAR-α is required for spermatogenesis; blocking that receptor (as with the experimental oral antagonist YCT-529) temporarily stops sperm production and is being tested as non-hormonal male contraception. See Vitamin A.

Pregnenolone and sperm

Pregnenolone (or DHEA, its downstream relative) has been used for infertility in men; a smaller amount, especially in older men, appears to increase sperm count and motility; larger amounts would likely suppress LH and lower testosterone synthesis instead. In 24 fertile men versus 18 men with infertility complaints, geometric-mean testosterone was similar in peripheral plasma and in testicular tissue, while infertile men had about 55% lower intratesticular pregnenolone, 64% lower androstenedione, and 32% lower DHT; plasma DHT was higher in the infertile group, and most intratesticular steroids were uncorrelated with plasma levels.

Mobile phone exposure

An updated meta-analysis of 39 human and animal studies found mobile-phone radiofrequency exposure associated with reduced sperm motility, viability, and concentration in the pooled data, though the human cross-sectional studies alone did not reach the same significance as the laboratory exposure studies. The effect is real in aggregate but not settled at the level of everyday phone use.

Heat and Sertoli cells

Heat stress raised arachidonic acid in testicular Sertoli cells. In cell culture, 100 µM arachidonic acid increased oxidative stress and autophagy in Sertoli cells, cut their oxygen consumption and shifted them toward glycolysis, indicating a dysfunctional mitochondrial respiratory chain. Sertoli cells support sperm maturation, so this is a proposed route from heat to male infertility.

Gut endotoxin

In mice, a week of daily endotoxin injections lowered sperm count and motility, and both were still low six weeks after the first dose. In mice given a single high dose, immature sperm cells broke away from the walls of the testis tubules and the genes for the junctions that seal off developing sperm were turned down. Human evidence is thinner. In a placebo-controlled trial, a single small endotoxin dose lowered testosterone in young men for less than a day, and sperm were not measured. See Endotoxin and Testosterone.

Red light and declining egg quality

Eggs contain several hundred times more mitochondria than any other cell, making egg quality with age primarily a matter of mitochondrial energy production rather than a fixed biological clock. Brief low-level red light exposure (15s irradiation of neck blood vessels, ~21 sessions) resulted in over 21% of infertile women of advanced reproductive age becoming pregnant; larger case series report pregnancy rates from 22% to 66% across different LLLT protocols. The proposed mechanism is displacement of nitric oxide (which blocks cytochrome c oxidase and cellular respiration), the same mechanism proposed for methylene blue and magnesium in restoring mitochondrial function.

Ovaries

The ovaries produce eggs and the sex steroids estrogen and progesterone. Cycle health tracks whole-body energy availability as much as it tracks gonadotropin signaling from the pituitary.

A common misreading of the cycle

Ray Peat corrected a common assumption that the luteal phase (after ovulation) is a low-estrogen phase dominated by progesterone alone. Both hormones actually rise together:

At the beginning of the luteal phase, both estrogen and progesterone normally rise several-fold, so the small increase in proliferative rate also correlates with estrogen levels.

— Ray Peat

The practical point is not that estrogen disappears in the luteal phase; adequate progesterone alongside it adequate progesterone alongside it keeps estrogen's proliferative, stimulating effects in check: progesterone's protective action is opposition, not the simple absence of estrogen. A multicenter reference-range study of 85 healthy women confirms the scale of both rises: median estradiol roughly doubles from the follicular phase to the luteal phase (198 to 412 pmol/L), while median progesterone rises about 136-fold over the same span (0.212 to 28.8 nmol/L).

When the balance shifts

Low thyroid function, high PUFA intake, and chronic stress all push the estrogen/progesterone balance toward unopposed estrogen dominance patterns: PMS, heavy cycles, and short luteal phases. In this framework, food and thyroid support are the first response, before supplement stacking.

PCOS

Ray Peat Wiki|description=Polycystic ovary syndrome (PCOS) in Ray Peat's framework: estrogen dominance over progesterone, not excess androgens, as the root imbalance.}}

Polycystic ovary syndrome (PCOS) is a common endocrine condition affecting an estimated 12% of women of child-bearing age in developed countries, causing irregular ovulation, infertility, acne, and elevated risk of diabetes, cardiovascular disease, and certain cancers. Gynecologic oncologists have directly linked the endometrial cancer risk in PCOS to the same estrogen/progesterone imbalance described below:

{{Quote|text=With PCOS you have a relative increase of estrogen relative to the levels of progesterone, which is the other female hormone and this causes thickening over time of the endometrial lining.|author=Dr. Bunja Rungruang, Augusta University Gynecological Oncology|source=WJBF-TV, "Doctors seeing more PCOS women with endometrial cancer," August 16, 2017, https://web.archive.org/web/20170822085906/http://wjbf.com/2017/08/16/doctors-seeing-more-pcos-women-with-endometrial-cancer/#:~:text=relative%20increase%20of

Mainstream medicine frames PCOS as a disorder of excess androgens ("hyperandrogenism"), treated with anti-androgen drugs. Ray Peat took the opposite position for decades: that excess estrogen, not androgens, is the underlying driver, with low thyroid function as the root cause upstream of both.

Mechanism: thyroid, estrogen, and stress rather than androgens

PCOS can be produced in animals by removing the thyroid gland. The inability of ovaries to make progesterone without thyroid causes the adrenals to be overstimulated, and they are the source of increased DHEA and other androgens and estrogen.

— Ray Peat

In this framework, low thyroid function impairs the ovaries' ability to produce Progesterone. The resulting lack of progesterone leaves Estrogen relatively unopposed, and the adrenal glands become overstimulated, raising DHEA and other androgens alongside estrogen itself. On this view, elevated androgens are a downstream marker of the same stress/estrogen-driven state, not the root cause, and the rise may be adaptive rather than incidental: prolonged stress promotes sodium loss, and androgens act directly on the kidney to increase sodium reabsorption, a mechanism demonstrated in female rats given testosterone, which developed higher blood pressure and lower urinary sodium excretion than untreated females on the same high-sodium diet.

Estrogen's causative role is also demonstrated directly in animal research: administering estradiol valerate (an estrogen ester similar to those used in some hormonal contraceptives) to rats for as little as 25-30 days reliably induces the polycystic ovarian changes, disrupted estrous cycles, and altered LH/FSH patterns characteristic of PCOS, a model that has been used in PCOS research since at least the 1980s.

DHT and androgens: protective rather than causative

Contrary to the standard "hyperandrogenism causes obesity/PCOS" model, cross-sectional research measuring plasma hormones directly against adipose tissue characteristics found the estrogens estrone (E1) and estrone sulfate (E1S), not androgens, correlated with obesity and larger fat cells; of the androgens measured, only DHT was associated with leanness. A placebo-controlled intervention trial giving postmenopausal women topical DHT for 6 months produced significant reductions in total body weight, abdominal fat, and overall body fat versus placebo.

Pomegranate juice lowered testosterone (MD -0.05), hs-CRP (SMD -0.85), and triglycerides (MD -23.30) and raised HDL (MD 6.21) across four randomized controlled trials in 128 women with PCOS, via polyphenol antioxidant and anti-inflammatory activity; LH, LDL, total cholesterol, and BMI did not change significantly.

This framework points toward the same general themes covered throughout this wiki rather than a PCOS-specific protocol: supporting thyroid function, lowering PUFA and Endotoxin, and favoring foods and practices that support Progesterone production over those that raise Estrogen. See the Roadmap for the general sequence, and Harm reduction before starting any hormone protocol. This page does not list doses.

See also

• Polycystic ovary syndrome